Mathew R P Sapiano1, Jefferson M Jones1, Alexandra A Savinkina1,2, Kathryn A Haass1, James J Berger3, Sridhar V Basavaraju1. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee. 3. U.S. Department of Health and Human Services, Office of HIV/AIDS and infectious Disease Policy, Office of the Assistant Secretary for Health, Washington, DC.
Abstract
INTRODUCTION: This report provides supplemental results from the 2017 National Blood Collection and Utilization Survey on characteristics of the donor population, autologous and directed donations and transfusions, platelets, plasma and granulocyte transfusions, pediatric transfusions, severe donor-related adverse events, cost of blood units, hospitals policies and practices, and inventory, dosing, and supply. METHODS: Weighting and imputation were used to generate national estimates including number of donors, donations, donor deferrals, autologous and directed donations and transfusions, severe donor-related adverse events, platelet and plasma collections and transfusions, number of cross-match procedures, irradiation and leukoreduction, and pediatric transfusions. RESULTS: Between 2015 and 2017, successful donations decreased slightly by 2.1% with a 10.3% decrease in donations by persons aged 16-18 years and a 14.4% increase in donations by donors aged >65 years. The median price paid for blood components by hospitals decreased from $211 to $207 for leukoreduced red blood cell units, from $523 to $517 for leukoreduced apheresis platelet units, and from $54 to $51 for fresh frozen plasma units. Plasma transfusions decreased 13.6%, but group AB plasma units transfused increased 24.7%. CONCLUSION: Between 2015 and 2017, blood donations declined slightly because of decreases in donations from younger donors, but the number of donations from older donors increased. The price hospitals pay for blood has continued to decrease. Plasma transfusions have decreased, but the proportion of plasma transfusions involving group AB plasma have increased. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.
INTRODUCTION: This report provides supplemental results from the 2017 National Blood Collection and Utilization Survey on characteristics of the donor population, autologous and directed donations and transfusions, platelets, plasma and granulocyte transfusions, pediatric transfusions, severe donor-related adverse events, cost of blood units, hospitals policies and practices, and inventory, dosing, and supply. METHODS: Weighting and imputation were used to generate national estimates including number of donors, donations, donor deferrals, autologous and directed donations and transfusions, severe donor-related adverse events, platelet and plasma collections and transfusions, number of cross-match procedures, irradiation and leukoreduction, and pediatric transfusions. RESULTS: Between 2015 and 2017, successful donations decreased slightly by 2.1% with a 10.3% decrease in donations by persons aged 16-18 years and a 14.4% increase in donations by donors aged >65 years. The median price paid for blood components by hospitals decreased from $211 to $207 for leukoreduced red blood cell units, from $523 to $517 for leukoreduced apheresis platelet units, and from $54 to $51 for fresh frozen plasma units. Plasma transfusions decreased 13.6%, but group AB plasma units transfused increased 24.7%. CONCLUSION: Between 2015 and 2017, blood donations declined slightly because of decreases in donations from younger donors, but the number of donations from older donors increased. The price hospitals pay for blood has continued to decrease. Plasma transfusions have decreased, but the proportion of plasma transfusions involving group AB plasma have increased. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.
Authors: G B Schreiber; U K Sharma; D J Wright; S A Glynn; H E Ownby; Y Tu; G Garratty; J Piliavin; T Zuck; R Gilcher Journal: Vox Sang Date: 2005-02 Impact factor: 2.144
Authors: Mark H Yazer; Bryon Jackson; Neil Beckman; Stuart Chesneau; Patrick Bowler; Meghan Delaney; Dana Devine; Stephen Field; Marc Germain; Mike F Murphy; Merlyn Sayers; Beth Shaz; Eilat Shinar; Minoko Takanashi; Ralph Vassallo; Crispin Wickenden; Vered Yahalom; Kevin Land Journal: Transfusion Date: 2016-06-24 Impact factor: 3.157
Authors: Jansen N Seheult; Beth Shaz; Marjorie Bravo; Harry Croxon; Dana Devine; Cheryl Doncaster; Stephen Field; Peter Flanagan; Marc Germain; Yves Grégoire; Hany Kamel; Matthew Karafin; Nancy Kelting; Marc Lewis; Cath O'Brien; Michael F Murphy; Susan Rossmann; Merlyn Sayers; Eilat Shinar; Minoko Takanashi; Kjell Titlestad; Mark H Yazer Journal: Transfusion Date: 2018-02-05 Impact factor: 3.157
Authors: Alexandra A Savinkina; Kathryn A Haass; Mathew R P Sapiano; Richard A Henry; James J Berger; Sridhar V Basavaraju; Jefferson M Jones Journal: Transfusion Date: 2020-03 Impact factor: 3.337
Authors: Stella T Chou; Perry Evans; Sunitha Vege; Sarita L Coleman; David F Friedman; Margaret Keller; Connie M Westhoff Journal: Blood Date: 2018-07-19 Impact factor: 22.113
Authors: Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce Journal: J Extra Corpor Technol Date: 2021-06
Authors: Jefferson M Jones; Mathew R P Sapiano; Sanjida Mowla; Dorothy Bota; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2021-06-24 Impact factor: 3.337
Authors: Christopher R France; Janis L France; Lina K Himawan; Kristen R Fox; Irina E Livitz; Brett Ankawi; P Maxwell Slepian; Jennifer M Kowalsky; Louisa Duffy; Debra A Kessler; Mark Rebosa; Shiraz Rehmani; Victoria Frye; Beth H Shaz Journal: Transfusion Date: 2021-07-05 Impact factor: 3.337
Authors: Sanjida J Mowla; Mathew R P Sapiano; Jefferson M Jones; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2021-08-01 Impact factor: 3.337
Authors: Jefferson M Jones; Mathew R P Sapiano; Alexandra A Savinkina; Kathryn A Haass; Misha L Baker; Richard A Henry; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2020-02-21 Impact factor: 3.337